Publications of G Hagberg

Kumlien, E.; Nilsson, A.; Hagberg, G.; Långström, B.; Bergström, M.: PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurologica Scandinavica 103 (6), pp. 360 - 366 (2001)

Mader, I.; Roser, W.; Kappos, L.; Hagberg, G.; Seelig, J.; Radue, E.; Steinbrich, W.: Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. American Journal of Neuroradiology 21 (7), pp. 1220 - 1227 (2000)

Lindström, L.; Gefvert, O.; Hagberg, G.; Lundberg, T.; Bergström , M.; Hartvig, P.; Långström, B.: Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET. Biological Psychiatry 46 (5), pp. 681 - 688 (1999)

Sihver, W.; Fasth, K.-J.; Horti, A.; Koren, A.; Bergström, M.; Lu, L.; Hagberg, G.; Lundqvist, H.; Dannals, R.; London, E. et al.; Nordberg, A.; Långström, B.: Synthesis and Characterization of Binding of 5-[76Br] Bromo-3-[[2(S)-Azetidinyl]methoxy]pyridine, a Novel Nicotinic Acetylcholine Receptor Ligand, in Rat Brain. Journal of Neurochemistry: official journal of the International Society for Neurochemistry 73 (3), pp. 1264 - 1272 (1999)

Tedroff, J.; Ekesbo, A.; Rydin, E.; Långström, B.; Hagberg, G.: Regulation of dopaminergic activity in early Parkinson's disease. Annals of Neurology 46 (3), pp. 359 - 365 (1999)

Hagberg, G.: From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods. NMR in Biomedicine 11 (4-5), pp. 148 - 156 (1998)

Hagberg, G.; Gefvert, O.; Bergström, M.; Wieselgren, I.-M.; Lindström, L.; Wiesel, F.-A.; Långström, B.: N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Research: Neuroimaging 82 (3), pp. 147 - 160 (1998)

Roser, W.; Hagberg, G.; Mader, I.; Dellas, S.; Seelig, J.; Radue, E.; Steinbrich, W.: Assignment of glial brain tumors in humans byin vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification. Magnetic Resonance Materials in Physics, Biology and Medicine 5 (3), pp. 179 - 183 (1997)

Mader, I.; Roser, W.; Hagberg, G.; Schneider, M.; Sauter, R.; Seelig, J.; Radue, E.; Steinbrich, W.: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. Magnetic Resonance Materials in Physics, Biology and Medicine 4 (2), pp. 139 - 150 (1996)

Hagberg, G.; Burlina, A.; Mader, I.; Roser, W.; Radue, E.; Seelig, J.: In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magnetic Resonance in Medicine 34 (2), pp. 242 - 252 (1995)

Roser, W.; Hagberg, G.; Mader, I.; Brunnschweiler, H.; Radue, E.; Seelig, J.; Kappos, L.: Proton MRS of Gadolinium-enhancing MS Plaques and Metabolic Changes in Normal-Appearing White Matter. Magnetic Resonance in Medicine 33 (6), pp. 811 - 817 (1995)

Garreffa, G.; Hagberg, G.; Indovina, L.: Physics of Hybrid Imaging. In: PET-CT and PET-MRI in Neurology, pp. 3 - 12 (Eds. Ciarmiello , A.; Mansi, L.). Springer, Cham, Switzerland (2016)

Hagberg, G.; Tuzzi, E.: Phase Variations in fMRI Time Series Analysis: Friend or Foe? In: Advanced Brain Neuroimaging Topics in Health and Disease: Methods and Applications, pp. 81 - 113 (Eds. Papageorgiou, T.; Christopoulos, G.; Smirnakis, S.). InTech, Rijeka, Croatia (2014)

Cherubini, A.; Luccichenti, G.; Fasano, F.; Hagberg, G.; Perán, P.; Di Salle, F.; Esposito, F.; Scarabino, T.; Sabatini, U.: Nerve Pathways with MR Tractography. In: High Field Brain MRI, pp. 79 - 90 (Eds. Salvolini, U.; scarabino, T.). Springer, Berlin, Germany (2006)

Giugni, E.; Luccichenti, G.; Hagberg, G.; Cherubini, A.; Fasano, F.; Sabatini, U.: High-Field Neuroimaging in Traumatic Brain Injury. In: High Field Brain MRI, pp. 169 - 176 (Eds. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Luccichenti, G.; Perán, P.; Cherubini, A.; Giugni, E.; Scarabino, T.; Hagberg, G.; sabatini, U.: High-Field 3 T Imaging of Alzheimer Disease. In: High Field Brain MRI, pp. 201 - 207 (Eds. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Perán, P.; Luccichenti, G.; Cherubini, A.; Hagberg, G.; Sabatini, U.: High-Field Neuroimaging in Parkinson’s Disease. In: High Field Brain MRI, pp. 194 - 200 (Eds. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Bianciardi, M.; Sirabella, P.; Hagberg, G.; Giuliani , A.; Zbilut, J.; Colosimo, A.: Analyzing Spatial Distributions of FMRI "Bold" Signals by RQA Variables. In: International Meeting Complexity in the Living: A Problem-Oriented Approach, pp. 238 - 243 (Eds. Benigni, R.; Colosimo, A.; Giuliani, A.; Sirabella, P.; Zbilut, J.). International Meeting Complexity in the Living: A Problem-Oriented Approach, Roma, Italy, September 28, 2001 - September 30, 2001. Istituto Superiore di Sanità, Roma, Italy (2004)

Hagberg, G.; Shiozawa, T.; Hirt, B.; Scheffler, K.: Comparison of quantitative MRI of the human brain measured ex vivo and in vivo at 9.4 T. In Magnetic Resonance Materials in Physics, Biology and Medicine, 37 (Supplement 1), O80, pp. S136 - S137. 40th Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB 2024), Barcelona, Spain, October 02, 2024 - October 05, 2024. No longer published by Elsevier, Amsterdam (2024)

Oleneva, P.; Hagberg, G.; Scheffler, K.: Building a scalable pipeline for detection of blood vessels in the human brainstem using quantitative susceptibility MRI at ultrahigh magnetic fields (UHF). In NeNa Conference 2022: Neurowissenschaftliche Nachwuchskonferenz (Conference of Junior Neuroscientists), T13, p. 14. 23rd Conference of Junior Neuroscientists (NeNa 2022), Bad Urach, Germany, October 10, 2022. (2022)